Achieving Precision with AI Pathology
from The Bio Report Hosted by Levine Media Group
Understanding the physical relationship of cells and how they interact can provide new understanding of diseases and help improve drug development and clinical treatment decisions. Nucleai uses its AI-powered spatial biology platform to transform pathology data into insights. The digital assays it develops enhances drug development, supports treatment decisions, and helps stratify patients to improve care. We spoke to Ken Bloom, head of pathology for Nucleai, about the company’s AI spatial biology platform, how it works, and the potential it has to advance precision medicine.
Embed this episode
What this episode covers
Ken Bloom, head of pathology for Nucleai, discusses the company’s AI spatial biology platform, how it works, and the potential it has to advance precision medicine.
No transcript yet.